Upton himself even admitted the fund might not be enough to cover everyone facing increases thanks to their pre-existing conditions. Andy previously served as the Acting Administrator of the Center for Medicare and Medicaid Services (CMS) under President Obama and Senior Advisor to the COVID-19 Response Team in the Biden administration.
"The number of times the words 'pre-existing conditions' are used in the bill. Slavitt (born 1966) 2 is an American businessman and healthcare advisor who served as the acting administrator of the Centers for Medicare and Medicaid Services from March 2015 to January 2017 and as a temporary Senior Advisor to the COVID-19 Response Coordinator in the Biden administration.
Slavitt, whose temporary position on Biden’s. doesn't have to be used for ppl w pre-existing conditions," Slavitt tweeted. Andy Slavitt, a senior advisor on President Joe Biden’s coronavirus response team, confirmed Friday he will be leaving his role in early June. "This $8B targeted to take care of ppl w pre-existing conditions. Yet according to Slavitt, the $8 billion fund is not only not enough to take care of all of the people who will potentially see cost increases because of the waivers, there's also nothing in the amendment text that requires the money be spent on people with pre-existing conditions. Upton hoped his amendment would win back votes from Republicans who were wary the AHCA would negatively impact sick Americans. The amendment was needed because the AHCA would allow states to waive a rule that requires insurance companies to charge people in the same age group and geographical area the same amount for insurance - regardless of whether they have pre-existing conditions. Slavitt was a senior COVID adviser in the Biden administration. Fred Upton (R-Mich.) tacked on an amendment to the AHCA that he said would create an $8 billion fund to offset potential cost increases for people with pre-existing conditions. Andy Slavitt has been thinking about that question, and he offers some answers in an essay in The Atlantic this week.
0 kommentar(er)
